"Your contribution to advancing life-changing medications is crucial. You not only have the opportunity to reap the benefits of safer more effective medicines for your own health, but also for the health of your family and generations to come. Receive Compensation for your Time and Travel. No Insurance Required. Participate in research and share your experience with others"

During the past decade, Ventavia Research Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ventavia Research Group" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ventavia Research Group" are "COVID-19" (1 trials), "Pneumococcal Disease" (1 trials), "Pneumococcal Infections" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "Ventavia Research Group" in a lesser frequency.

Most popular intervention types in "Ventavia Research Group" are "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "13vPnC" (1 trials), "20vPnC" (1 trials), "BNT162b2" (1 trials), "BNT162b2 OMI" (1 trials) and "Combination (Bivalent) BNT162b2 and BNT162b2 OMI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ventavia Research Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ventavia Research Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ventavia Research Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ventavia Research Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".